Suppr超能文献

巨梁型和血管包绕肿瘤簇的肝细胞癌的免疫表型和肿瘤免疫微环境。

Immunophenotypes and Tumor Immune Microenvironment in Hepatocellular Carcinoma With Macrotrabecular Massive and Vessels Encapsulating Tumor Clusters.

机构信息

Department of Diagnostic Pathology, Kurume University Hospital, Kurume, Japan;

Department of Pathology, Kurume University School of Medicine, Kurume, Japan.

出版信息

In Vivo. 2024 Mar-Apr;38(2):640-646. doi: 10.21873/invivo.13483.

Abstract

BACKGROUND/AIM: Recently, vessels encapsulating tumor clusters (VETC) pattern and macrotrabecular massive (MTM) pattern of hepatocellular carcinoma (HCC) have been reported as aggressive histological types. These histological patterns showed an immunosuppressive tumor immune microenvironment (TIME). Since there have been no reports on the differences of these two subtypes simultaneously, this study examined the immunophenotypes and TIME of MTM-HCC and VETC-HCC immunohistochemically.

PATIENTS AND METHODS

Seventy-four cases of previously diagnosed HCC, including 32 MTM-HCCs, 21 VETC-HCCs, and 21 conventional HCCs, were enrolled in immunohistochemical analysis. We conducted immunohistochemical analysis.

RESULTS

We found that MTM-HCC showed less frequent expression of HepPar-1, which is one of the most common hepatocytic markers. In MTM-HCC, the frequency of high expression levels of Keratin19, carbonic anhydrase (CA) IX, and PD-L1 was higher compared to VETC-HCC and conventional HCC. PD-L1 expression was found in 34.4% of MTM-HCC, 0% of VETC-HCC, and 19.0% of conventional HCC. The rate of PD-L1 expression in MTM-HCC was significantly higher than the others (p=0.0015). PD-L1 expression was significantly associated with epithelial cell adhesion molecules and CA IX expression, which are representative markers of tumor stemness and hypoxic conditions, respectively. The CD8 infiltration in VETC-HCC was significantly lower than that in conventional HCC.

CONCLUSION

MTM-HCC had different immunophenotypes and TIMEs compared to HCC with the VETC pattern. Although both had immunosuppressive TIME, the elements forming TIME were quite different. To enhance the immune checkpoint inhibitor efficacy, changing TIME from a suppressive to an active form is essential.

摘要

背景/目的:最近,报道了肝癌(HCC)的血管包裹肿瘤簇(VETC)模式和巨梁状大量(MTM)模式,这些组织学类型被认为是侵袭性较强的组织学类型。这些组织学模式表现出免疫抑制的肿瘤免疫微环境(TIME)。由于目前尚无同时报告这两种亚型差异的报道,本研究通过免疫组织化学方法研究了 MTM-HCC 和 VETC-HCC 的免疫表型和 TIME。

患者和方法

共纳入 74 例既往诊断为 HCC 的患者,包括 32 例 MTM-HCC、21 例 VETC-HCC 和 21 例常规 HCC。我们进行了免疫组织化学分析。

结果

我们发现 MTM-HCC 中 HepPar-1 的表达频率较低,HepPar-1 是最常见的肝细胞标志物之一。在 MTM-HCC 中,角蛋白 19、碳酸酐酶(CA)IX 和 PD-L1 的高表达频率高于 VETC-HCC 和常规 HCC。在 MTM-HCC 中发现 34.4%、VETC-HCC 中 0%和常规 HCC 中 19.0%的 PD-L1 表达。MTM-HCC 的 PD-L1 表达率明显高于其他两组(p=0.0015)。PD-L1 表达与上皮细胞黏附分子和 CA IX 表达显著相关,CA IX 是肿瘤干性和缺氧条件的代表性标志物。VETC-HCC 中的 CD8 浸润明显低于常规 HCC。

结论

与 VETC 模式的 HCC 相比,MTM-HCC 具有不同的免疫表型和 TIME。尽管两者均具有免疫抑制性 TIME,但构成 TIME 的元素却有很大的不同。为了提高免疫检查点抑制剂的疗效,将 TIME 从抑制状态转变为激活状态至关重要。

相似文献

本文引用的文献

5
Immunotherapies for hepatocellular carcinoma.肝细胞癌的免疫疗法
Nat Rev Clin Oncol. 2022 Mar;19(3):151-172. doi: 10.1038/s41571-021-00573-2. Epub 2021 Nov 11.
7
Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer.派姆单抗治疗持续性、复发性或转移性宫颈癌。
N Engl J Med. 2021 Nov 11;385(20):1856-1867. doi: 10.1056/NEJMoa2112435. Epub 2021 Sep 18.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验